TRIM14 promotes cell proliferation and inhibits apoptosis by suppressing PTEN in colorectal cancer

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Kuiper JG, Phipps AI, Neuhouser ML, et al. Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control. 2012;23(12):1939–1948. doi:10.1007/s10552-012-0071-223053793
   PubMed Web of Science ®Google Scholar
• Slattery ML. Diet, lifestyle, and colon cancer. Semin Gastrointest Dis. 2000;11(3):142–146.10950460
   PubMedGoogle Scholar
• Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer. 2009;125(1):171–180. doi:10.1002/ijc.2434319350627
   PubMed Web of Science ®Google Scholar
• Meroni G, Diez‐Roux G. TRIM/RBCC, a novel class of ‘single protein RING finger’E3 ubiquitin ligases. Bioessays. 2005;27(11):1147–1157. doi:10.1002/bies.2030416237670
   PubMed Web of Science ®Google Scholar
• Ozato K, Shin D-M, Chang T-H, Morse HC III. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol. 2008;8(11):849–860. doi:10.1038/nri241318836477
   PubMed Web of Science ®Google Scholar
• Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer. 2011;11(11):792–804. doi:10.1038/nrc313921979307
   PubMed Web of Science ®Google Scholar
• Tarantul V, Nikolaev A, Hannig H, et al. Detection of abundantly transcribed genes and gene translocation in human immunodeficiency virus-associated non-Hodgkin’s lymphoma. Neoplasia. 2001;3(2):132–142. doi:10.1038/sj/neo/790013711420749
   PubMed Web of Science ®Google Scholar
• Tan P, He L, Cui J, et al. Assembly of the WHIP-TRIM14-PPP6C mitochondrial complex promotes RIG-I-mediated antiviral signaling. Mol Cell. 2017; 68(2):293–307. e295. doi:10.1016/j.molcel.2017.09.03529053956
   PubMed Web of Science ®Google Scholar
• Wang S, Chen Y, Li C, et al. TRIM14 inhibits hepatitis C virus infection by SPRY domain-dependent targeted degradation of the viral NS5A protein. Sci Rep. 2016;6:32336. doi:10.1038/srep3233627578425
   PubMed Web of Science ®Google Scholar
• Hai J, Zhu CQ, Wang T, Organ SL, Shepherd FA, Tsao MS. TRIM14 is a putative tumor suppressor and regulator of innate immune response in non-small cell lung cancer. Sci Rep. 2017;7:39692. doi:10.1038/srep3969228059079
   PubMed Web of Science ®Google Scholar
• Xu G, Guo Y, Xu D, et al. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway. Sci Rep. 2017;7:42411. doi:10.1038/srep4241128205534
   PubMed Web of Science ®Google Scholar
• Wang T, Ren Y, Liu R, et al. miR-195-5p suppresses the proliferation, migration, and invasion of oral squamous cell carcinoma by targeting TRIM14. Biomed Res Int. 2017;2017:1–13. doi:10.1155/2017/6490349
   Web of Science ®Google Scholar
• Su X, Wang J, Chen W, Li Z, Fu X, Yang A. Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-kappaB signaling pathway. Oncotarget. 2016;7(9):9939–9950. doi:10.18632/oncotarget.694126799420
   PubMedGoogle Scholar
• Dong B, Zhang W. High levels of TRIM14 are associated with poor prognosis in hepatocellular carcinoma. Oncol Res Treat. 2018;41(3):129–134. doi:10.1159/00048562529485416
   PubMed Web of Science ®Google Scholar
• Mayer IA, Arteaga CL. The PI3K/AKT pathway as a target for cancer treatment. Annu Rev Med. 2016;67:11–28. doi:10.1146/annurev-med-062913-05134326473415
   PubMed Web of Science ®Google Scholar
• Huang XF, Chen JZ. Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev. 2009;10(6):610–616. doi:10.1111/j.1467-789X.2009.00607.x19527447
   PubMed Web of Science ®Google Scholar
• Suman S, Kurisetty V, Das TP, et al. Activation of AKT signaling promotes epithelial–mesenchymal transition and tumor growth in colorectal cancer cells. Mol Carcinog. 2014;53:S1. doi:10.1002/mc.22076
   PubMed Web of Science ®Google Scholar
• Martini M, De Santis MC, Braccini L, Gulluni F, Hirsch E. PI3K/AKT signaling pathway and cancer: an updated review. Ann Med. 2014;46(6):372–383. doi:10.3109/07853890.2014.91283624897931
   PubMed Web of Science ®Google Scholar
• Colakoglu T, Yildirim S, Kayaselcuk F, et al. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence? Am J Surg. 2008;195(6):719–725. doi:10.1016/j.amjsurg.2007.05.06118440486
   PubMed Web of Science ®Google Scholar
• Sun Y, Tian H, Wang L. Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway. Oncol Rep. 2015;33(4):1828–1836. doi:10.3892/or.2015.380425683168
   PubMed Web of Science ®Google Scholar
• Jin Z, Li H, Hong X, et al. TRIM14 promotes colorectal cancer cell migration and invasion through the SPHK1/STAT3 pathway. Cancer Cell Int. 2018;18(1):202.30555277
   PubMed Web of Science ®Google Scholar
• Pugazhenthi S, Nesterova A, Sable C, et al. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem. 2000;275(15):10761–10766. doi:10.1074/jbc.275.15.1076110753867
   PubMed Web of Science ®Google Scholar
• Fatrai S, Elghazi L, Balcazar N, et al. Akt induces β-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes. 2006;55(2):318–325. doi:10.2337/diabetes.55.02.06.db05-075716443763
   PubMed Web of Science ®Google Scholar
• Sun H, Lesche R, Li D-M, et al. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3, 4, 5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A. 1999;96(11):6199–6204. doi:10.1073/pnas.96.11.619910339565
   PubMed Web of Science ®Google Scholar
• Zhou Z, Jia X, Xue Q, et al. TRIM14 is a mitochondrial adaptor that facilitates retinoic acid-inducible gene-I-like receptor-mediated innate immune response. Proc Natl Acad Sci U S A. 2014;111(2):E245–E254. doi:10.1073/pnas.131694111124379373
   PubMed Web of Science ®Google Scholar
• Wang J, Zhu J, Dong M, Yu H, Dai X, Li K. Knockdown of tripartite motif containing 24 by lentivirus suppresses cell growth and induces apoptosis in human colorectal cancer cells. Oncol Res. 2014;22(1):39–45. doi:10.3727/096504014X1407843600501225700357
   PubMed Web of Science ®Google Scholar
• Wang F-Q, Han Y, Yao W, Yu J. Prognostic relevance of tripartite motif containing 24 expression in colorectal cancer. Pathol Res Pract. 2017;213(10):1271–1275. doi:10.1016/j.prp.2017.08.00828916426
   PubMed Web of Science ®Google Scholar
• Jiang T, Tang HM, Lu S, Yan DW, Yang YX, Peng ZH. Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer. Med Oncol. 2013;30(4):715. doi:10.1007/s12032-013-0715-424078150
   PubMed Web of Science ®Google Scholar
• Xu W, Xu B, Yao Y, et al. RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells. Oncol Rep. 2016;36(3):1411–1418. doi:10.3892/or.2016.494127430345
   PubMed Web of Science ®Google Scholar
• Malinowsky K, Nitsche U, Janssen K, et al. Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer. Br J Cancer. 2014;110(8):2081–2089. doi:10.1038/bjc.2014.10024619078
   PubMed Web of Science ®Google Scholar
• Dong M, Yang G, Liu H, et al. Aged black garlic extract inhibits HT29 colon cancer cell growth via the PI3K/Akt signaling pathway. Biomed Rep. 2014;2(2):250–254. doi:10.3892/br.2014.22624649105
   PubMedGoogle Scholar
• Li XX, Huang LY, Peng JJ, et al. Klotho suppresses growth and invasion of colon cancer cells through inhibition of IGF1R-mediated PI3K/AKT pathway. Int J Oncol. 2014;45(2):611–618. doi:10.3892/ijo.2014.243024818842
   PubMed Web of Science ®Google Scholar
• Enayat S, Mş C, Başaran AA, Gürsel M, Banerjee S. Anticarcinogenic effects of the ethanolic extract of Salix aegyptiaca in colon cancer cells: involvement of Akt/PKB and MAPK pathways. Nutr Cancer. 2013;65(7):1045–1058. doi:10.1080/01635581.2013.85096624168160
   PubMed Web of Science ®Google Scholar
• Trotman LC, Wang X, Alimonti A, et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell. 2007;128(1):141–156. doi:10.1016/j.cell.2006.11.04017218261
   PubMed Web of Science ®Google Scholar
• Lee JT, Shan J, Zhong J, et al. RFP-mediated ubiquitination of PTEN modulates its effect on AKT activation. Cell Res. 2013;23(4):552–564. doi:10.1038/cr.2013.2723419514
   PubMed Web of Science ®Google Scholar